Cyberounds Logo
May 16, 2012 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
The Medical Treatment of Lipid Disorders
CME credit is no longer available for this conference.
Ernst John Schaefer, M.D., and Robert M. Russell, M.D.

Ernst John Schaefer is professor of medicine at Tufts University School of Medicine, Director of the Heart Disease Prevention Program at New England Medical Center, and senior scientist and Chief, Lipid Metabolism Laboratory of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. He graduated from Harvard College, Dartmouth Medical School and Mt. Sinai School of Medicine, trained in internal medicine at Mt. Sinai and in endocrinology and lipoprotein research at the National Institutes of Health. Dr. Schaefer served on the first and second Adult Treatment Panels of the National Cholesterol Education Program which generated U.S. guidelines for cholesterol management. He is the U.S. editor of the journal Atherosclerosis. His research focuses on the nutritional and genetic regulation of plasma lipoproteins. Dr. Schaefer reports no commercial conflict of interest. In the last three years, Dr. Russell has received grant/research support from BASF and Roche Vitamins. Dr. Russell has also served as a consultant for Whitehall Robbins-Quaker.


Release Date: 06/30/1998
Termination Date: 06/30/2001

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Classify lipid disorders by the use of individual laboratory values for LDL cholesterol, HDL cholesterol and triglyceride
  • Identify which drugs are used for which lipid disorders
  • Identify the secondary causes of hypercholesterolemia.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity